| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.099 | 0.002 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |